ALEC
Alector, Inc.
Key Financials
Net Income
$-142929000
↓ 20.1%
Revenue
$21.0M
↓ 79.1%
Operating Income
$-156007000
↓ 7.6%
EPS (Diluted)
$-1.39
↓ 13.0%
Total Assets
$293.2M
↓ 37.4%
Total Liabilities
$262.6M
↓ 23.1%
Shareholders' Equity
$30.6M
↓ 75.8%
Long-term Debt
$10.0M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 9/18/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| 144 | 9/4/2026 | View on SEC |
| 144 | 9/2/2026 | View on SEC |
| 144 | 9/1/2026 | View on SEC |
| 144 | 9/1/2026 | View on SEC |
| 144 | 9/1/2026 | View on SEC |
| 4 | 8/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ALEC |
| Company Name | Alector, Inc. |
| CIK | 1653087 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 415-231-5660 |